Pursuant to Article 13 of the Academic Regulations of the Master’s Degree Program in Pharmaceutical Chemistry and Technology, in order to be admitted to the final examination, the student must:
a) submit an application for thesis assignment to the Student Office, countersigned by the Supervisor and forwarded through the Director, at least 6 months before the starting date of the first available graduation session. For this purpose, the date of receipt by the protocol office shall be considered binding. For students participating in mobility programs, this requirement shall be certified by the internationalization coordinator;
b) have acquired all the credits required by the Study Plan, with the exception of those assigned to the final examination, and be up to date with the payment of university tuition fees and contributions;
c) have submitted an application to the Rector before the date set for the Master’s Degree examination, within the deadlines established by the University, and have deposited an electronic copy (PDF file) of the final thesis, countersigned by the Supervisor, through the appropriate online procedure on Esse3, at least 7 working days before the final examination.
The final examination for the award of the Master’s Degree in Pharmaceutical Chemistry and Technology consists of the presentation and discussion of a thesis relating to the experimental activity carried out under the guidance of the Supervisor, on the basis of which the Examination Board may assess the student’s cultural and scientific maturity as well as the quality of the work performed. In the preparation of the thesis, the student may avail themselves of the collaboration of a Co-supervisor, who may be a faculty member from another university, including a foreign one, or an external professional figure, including of another nationality.
The thesis, which may be written partially or entirely in English and must be signed by the Supervisor, must be submitted by the candidate to the competent administrative offices at least 7 working days before the final examination.
The evaluation of the final examination thesis takes place during the graduation session by the Graduation Examination Board, composed of at least seven members, appointed by the Director of the Department upon proposal of the Degree Program Coordinator. In order to pass the final examination, a minimum score of 66/110 is required. The maximum score is 110/110, with the possible award of honors (cum laude).
The final Master’s Degree grade, expressed on a scale of one hundred and ten, is determined by the following components: the base score, calculated as the weighted average of the grades obtained in curricular examinations; the curricular score (maximum 4 points), which takes into account the activities carried out by the student during their academic career (international mobility, completion of studies within the prescribed time, acquisition of honors, etc.); and the thesis evaluation score (maximum 7 points).
For the thesis evaluation score, the Examination Board shall take into account the quality of the thesis work, the effort devoted to the preparation of the thesis, the candidate’s presentation skills, and their ability to answer the questions posed by the Board in a relevant manner. Honors may be awarded, upon proposal of the Supervisor and with the unanimous approval of the Examination Board, only to theses judged to be of high quality by the Board.
The final Master’s Degree examinations are held in public, as is the official proclamation of the final result.
For further details concerning the final examination, reference is made to Article 13 of the Regulations of the Master’s Degree Program in Pharmaceutical Chemistry and Technology (CTF).